ClinicalTrials.gg
CompletedNCT07248098IleusUpdated Mar 20, 2026

Abdominal Hot Water Bag Aplication Ileus Care

An interventional study of hot water application in Ileus, Nursing Care and Pain, sponsored by Cukurova University. Completed at 1 site in Turkey (Türkiye). Open to participants aged 18 Years and older, including healthy volunteers. Per ClinicalTrials.gov, last updated 2026-03-20.

Sponsored by Cukurova University · Not applicable, Interventional, and Supportive care

From the registry’s dates

  • Registered 11 months after the study started (first participant enrolled Oct 2024, registered Sep 2025).
Phase
Not applicable
Study type
Interventional
Enrollment
60
Allocation
Randomized
Ages
18 Years and older
Sex
All
01

Study summary

The role of nurses in the management of ileus is very important as they are part of the multidisciplinary approach. The study aimed to determine the effect of a hot water bag applied to the abdominal region on pain caused by decreased or cessation of intestinal peristalsis in individuals diagnosed with ileus on reducing or relieving pain and restoring intestinal peristalsis.

Read the detailed description

The study aimed to determine the effect of a hot water bag applied to the abdominal region on pain caused by decreased or cessation of intestinal peristalsis in individuals diagnosed with ileus on reducing or relieving pain and restoring intestinal peristalsis. Data will be evaluated using a literature-based Patient Personal Information Form, Visual Analog Scale, burping, and auscultation of bowel sounds with a stethoscope. Sample calculations were performed using a priori power analysis (t-test) for the intervention and control groups. Accordingly, with an effect size of d=2.06, a 5% error rate (α=0.01), and 99% power (1-β=0.99), the minimum sample size for both groups was calculated as 54. Considering potential losses, the total sample size was increased by 10%, resulting in 30 patients in each group (Experimental Group: 30, Control Group: 30), and a total of 60 patients.

02

Conditions studied

  • Ileus
  • Nursing Care
  • Pain

Browse trials for

Keywords

  • ileus
  • nursing care
  • pain
  • water treatment
03

In context

Ileus

167 studies on the registry are indexed under Ileus; 23 are open to participants now.

This study's enrollment of 60 is below the median of 90 across 138 interventional studies indexed under Ileus.

Browse Ileus studies →

Lead sponsor

Cukurova University is the lead sponsor of 259 studies on the registry; 50 are open to participants now.

Counted across the registry records on this site, refreshed daily.

04

Who can participate

Ages eligible
18 Years and older
Sexes eligible
All
Accepts healthy volunteers
Yes

Go through the criteria one by one — yes, no or not sure — and take the list to your doctor or the study team. Kept in this browser only.

Inclusion criteria

  • Agreeing to participate in the study,
  • No communication or intellectual disabilities,
  • Reading and writing skills,
  • Diagnosed with brid ileus, as a type of ileus,
  • Adult individuals over the age of 18

Exclusion criteria

Exclusion Criteria:

  • Leaving the study
05

Study design

Phase
Not applicable
Primary purpose
Supportive care
Allocation
Randomized
Intervention model
Parallel assignment
Masking
Single (Participant)
Enrollment
60 participants (actual)

Study arms

  • Experimental
    intervention

    hot water application

    Other: hot water application

  • No intervention
    control

    standart care

Interventions

  • Otherhot water application

    hot water application

06

What researchers measure

Primary outcomes

  1. Visiual Analog Scale

    It is scored from 1 to 10. The lowest score is 0, meaning no pain, and the highest score is 10, meaning unbearable pain. The higher the score, the greater the pain.

    Time frame: 30 day

07

Study locations

1 site
  • Cukurova University
    Adana, Saricam 01330, Turkey (Türkiye)
08

References and documents

Individual participant data

Plan to share: No

No publications or documents are linked to this record.

09

Timeline

Tracking since Sep 25, 2026
ElapsedEstimatedEstimated, not yet reachedSimilar studies: half by the dot; the band is the middle halfHalf of similar studies reached it by the dot; the band is the middle half, from a quarter to three quarters

Ran from Oct 2024 to primary completion in Nov 2025, 13 months.

Of 40 non-industry interventional studies with no phase under Ileus, half reached primary completion within 19 months of starting (the median), counting those still running; a quarter within 7 and three quarters within 53. This study's 13 months is below that.

Counting every sponsor, half of 40 studies reached it within 19 months; a quarter within 7 and three quarters within 53.

How these figures are worked out, and which studies are left out of them.

Registered
Sep 17, 2025
First posted
Nov 25, 2025
StartActual
Oct 1, 2024
Primary completionActual
Nov 22, 2025
CompletionActual
Nov 25, 2025
Last update
Mar 20, 2026
What these dates mean
Start.
When the first participant enrolled; while estimated, when the study expects to open to recruitment.
Primary completion.
When the last participant was examined or treated to collect data for the study's main question, its primary outcome. A study that stopped early gives the date its data collection stopped.
Completion.
When the last participant's last visit took place, for every outcome, secondary ones and side effects included: the end of the study. Often later than primary completion, sometimes the same day.
Actual and Est.
Actual means the registry says the date has happened. Est. (estimated) is a date the sponsor plans or expects. It can still move, and the sponsor is expected to change it to actual once it has passed.
No changes since tracking began. The registry record was last updated on Mar 20, 2026, before this site started recording changes on Sep 25, 2026. Its history is on ClinicalTrials.gov ↗
10

Registry details

Key details

Study ID
NCT07248098
Responsible party
Meltem Akbaş (Dr, Cukurova University) — Principal investigator
First posted
Nov 25, 2025
Start date
Oct 1, 2024
Primary completion
Nov 22, 2025
Completion
Nov 25, 2025
Last update
Mar 20, 2026

Study contacts

Meltem Akbaş, Dr
principal investigator · Cukurova University

Oversight

Data monitoring committee
No
FDA-regulated drug
No
FDA-regulated device
No
View the source record on ClinicalTrials.gov ↗

Not currently enrolling

This study is completed, as verified in Mar 2026. You cannot join it, but the record below documents what was studied.

Follow this study

Get an email when the registry record changes — status, dates, results — or when someone posts here.

Sign in to follow

Discussion

Questions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.

Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.

Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.

Start the discussion